Dapagliflozin significantly shortened the time to clinical benefit in patients with heart failure with reduced ejection fraction compared to those with prior hospitalization for heart failure.
ClinicalTrials.gov Identifier NCT03036124.
Building similarity graph...
Analyzing shared references across papers
Loading...
David D. Berg
Pardeep S. Jhund
Kieran F. Docherty
JAMA Cardiology
Yale University
University of Toronto
Brigham and Women's Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Berg et al. (Sat,) reported a other. Dapagliflozin significantly shortened the time to clinical benefit in patients with heart failure with reduced ejection fraction compared to those with prior hospitalization for heart failure.
www.synapsesocial.com/papers/696910e587f73b5c2af0cede — DOI: https://doi.org/10.1001/jamacardio.2020.7585